β-Nor-lapachone

目录号: HY-146067: FAQs
Data Sheet 产品使用指南技术支持

β-Nor-lapachone 是一种光滑念珠菌 (Candida glabrata) 的抗生物膜剂。β-Nor-lapachone 能刺激 ROS 的产生，抑制光念珠菌的流动活性、粘附、生物膜形成和成熟生物膜代谢。β-Nor-lapachone 具有抗真菌活性。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

β-Nor-lapachone Chemical Structure

CAS No. : 52436-88-1

1. 客户无需承担相应的运输费用。

2. 同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

可免费申领三个不同产品的试用装。

3. 试用装只面向终端客户。

规格		是否有货
50 mg		询价
100 mg		询价
250 mg		询价

or 大包装询价

* Please select Quantity before adding items.

Customer Review

β-Nor-lapachone 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性
纯度 & 产品资料
参考文献

生物活性

β-Nor-lapachone is a Candida glabrata antibiofilm agent. β-Nor-lapachone can stimulate ROS production, inhibits efflux activity, adhesion, biofilm formation and the metabolism of mature biofilms of Candida glabrata. β-Nor-lapachone has antifungal activity^[1].

IC₅₀ & Target

Candida glabrata, ROS^[1]

细胞效力
(Cellular Effect)

Cell Line	Type	Value	Description	References
A549	IC₅₀	10 μM Compound: 3	Cytotoxicity against human A549 cells after 72 hrs by MTT assay Cytotoxicity against human A549 cells after 72 hrs by MTT assay	[PMID: 25677663]
A549	IC₅₀	20 μM Compound: 3	Cytotoxicity against human A549 cells after 72 hrs by MTT assay in presence of NQO1 inhibitor dicoumarol Cytotoxicity against human A549 cells after 72 hrs by MTT assay in presence of NQO1 inhibitor dicoumarol	[PMID: 25677663]
CCRF-CEM	IC₅₀	15.2 μM Compound: 8	Cytotoxicity against human CCRF-CEM cells after 48 hrs by Alamar blue assay Cytotoxicity against human CCRF-CEM cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
DU-145	IC₅₀	1.386 μM Compound: Page 1994, R38C1	Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human DU145 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
DU-145	IC₅₀	2.382 μM Compound: Page 1994, R38C1	Cytotoxicity against human DU145 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human DU145 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
Erythrocyte	EC₅₀	> 50 μg/mL Compound: 2	Toxicity in mouse erythrocytes assessed as hemolytic activity after 30 mins by spectrophotometry Toxicity in mouse erythrocytes assessed as hemolytic activity after 30 mins by spectrophotometry	[PMID: 19947600]
HCT-116	IC₅₀	1.41 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
HCT-116	IC₅₀	1.575 μM Compound: Page 1994, R38C1	Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
HCT-116	IC₅₀	7.482 μM Compound: Page 1994, R38C1	Cytotoxicity against human HCT116 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
HCT-8	IC₅₀	0.31 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay	[PMID: 17827021]
HCT-8	IC₅₀	1.36 μM Compound: 26	Cytotoxicity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human HCT-8 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
HCT-8	IC₅₀	1.36 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay	[PMID: 21115213]
HCT-8	IC₅₀	1.36 μM Compound: 2	Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay	[PMID: 19947600]
HL-60	IC₅₀	0.4 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 17827021]
HL-60	IC₅₀	1.75 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
HL-60	IC₅₀	1.75 μM Compound: 26	Cytotoxicity against human HL-60 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human HL-60 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
HL-60	IC₅₀	1.75 μM Compound: Nor-beta-lapachone	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 21115213]
HL-60	IC₅₀	1.75 μM Compound: 2	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 19947600]
J774.A1	IC₅₀	3.69 μg/mL Compound: 5a; nor-beta-lap	Cytotoxicity against mouse J774.A1 cells measured after 24 hrs by resazurin based assay Cytotoxicity against mouse J774.A1 cells measured after 24 hrs by resazurin based assay	[PMID: 31378595]
Jurkat	IC₅₀	1.34 μM Compound: 26	Cytotoxicity against human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human Jurkat cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
K562	IC₅₀	2.28 μM Compound: 8	Cytotoxicity against human K562 cells after 48 hrs by Alamar blue assay Cytotoxicity against human K562 cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
KG-1	IC₅₀	17.2 μM Compound: 8	Cytotoxicity against human KG1 cells after 48 hrs by Alamar blue assay Cytotoxicity against human KG1 cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
MDA-MB-435	IC₅₀	0.07 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay	[PMID: 17827021]
MDA-MB-435	IC₅₀	0.31 μM Compound: 26	Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
MDA-MB-435	IC₅₀	0.31 μM Compound: Nor-beta-lapachone	Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay	[PMID: 21115213]
MDA-MB-435	IC₅₀	0.31 μM Compound: 2	Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay Cytotoxicity against human MDA-MB-435 cells after 72 hrs by MTT assay	[PMID: 19947600]
MOLT-4	IC₅₀	13.6 μM Compound: 8	Cytotoxicity against human MOLT4 cells after 48 hrs by Alamar blue assay Cytotoxicity against human MOLT4 cells after 48 hrs by Alamar blue assay	[PMID: 25064348]
OVCAR-8	IC₅₀	1.25 μM Compound: Nor-beta-lapachone	Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay Cytotoxicity against human OVCAR8 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
OVCAR-8	IC₅₀	13.737 μM Compound: Page 1994, R38C1	Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
OVCAR-8	IC₅₀	2.579 μM Compound: Page 1994, R38C1	Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human OVCAR8 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
PBMC	IC₅₀	> 21.9 μM Compound: Nor-beta-lapachone	Cytotoxicity against human PBMC cells after 72 hrs by Alamar Blue assay Cytotoxicity against human PBMC cells after 72 hrs by Alamar Blue assay	[PMID: 21115213]
PBMC	IC₅₀	> 21.9 μM Compound: 2	Cytotoxicity against human PBMC after 72 hrs by alamar blue assay Cytotoxicity against human PBMC after 72 hrs by alamar blue assay	[PMID: 19947600]
PBMC	IC₅₀	> 21.9 μM Compound: Nor-beta-lapachone	Cytotoxicity against human PBMC cells after 72 hrs by MTT assay Cytotoxicity against human PBMC cells after 72 hrs by MTT assay	10.1039/C4MD00371C
PBMC	IC₅₀	10 μM Compound: Page 1994, R38C1	Cytotoxicity against human PBMC assessed as decrease in cell viability after 72 hrs by Alamar blue assay Cytotoxicity against human PBMC assessed as decrease in cell viability after 72 hrs by Alamar blue assay	[PMID: 30108718]
PBMC	IC₅₀	10 μM Compound: Page 1994, R38C1	Cytotoxicity against human PBMC assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by Alamar blue assay Cytotoxicity against human PBMC assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by Alamar blue assay	[PMID: 30108718]
PBMC	IC₅₀	2.1 μM Compound: 28, Nor-beta-lapachone	Cytotoxicity against human PBMC after 72 hrs by alamar blue assay Cytotoxicity against human PBMC after 72 hrs by alamar blue assay	[PMID: 20378360]
PC-3	IC₅₀	1.453 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human PC3 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
PC-3	IC₅₀	1.854 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human PC3 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	1.401 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 96 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 96 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	1.787 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 96 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 96 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	1.887 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 24 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 24 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	2.442 μg/mL Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 24 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 24 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	4.587 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]
PC-3M	IC₅₀	8.969 μM Compound: Page 1994, R38C1	Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human PC3M cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
Peritoneal macrophage cell	CC₅₀	1.55 μM Compound: Nor-beta-lapachone	Cytotoxicity against Swiss mouse peritoneal macrophages after 24 hrs by MTT assay Cytotoxicity against Swiss mouse peritoneal macrophages after 24 hrs by MTT assay	[PMID: 23535320]
SF-295	IC₅₀	0.36 μg/mL Compound: 2a, beta-lapachone	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	[PMID: 17827021]
SF-295	IC₅₀	1.447 μM Compound: Page 1994, R38C1	Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay Cytotoxicity against human SF295 cells assessed as decrease in cell viability after 72 hrs by MTT assay	[PMID: 30108718]
SF-295	IC₅₀	1.58 μM Compound: Nor-beta-lapachone	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	10.1039/C4MD00371C
SF-295	IC₅₀	1.58 μM Compound: 26	Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay Cytotoxicity against human SF-295 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay	[PMID: 33158575]
SF-295	IC₅₀	1.58 μM Compound: Nor-beta-lapachone	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	[PMID: 21115213]
SF-295	IC₅₀	1.58 μM Compound: 2	Cytotoxicity against human SF295 cells after 72 hrs by MTT assay Cytotoxicity against human SF295 cells after 72 hrs by MTT assay	[PMID: 19947600]
SF-295	IC₅₀	7.404 μM Compound: Page 1994, R38C1	Cytotoxicity against human SF295 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay Cytotoxicity against human SF295 cells assessed as decrease in cell viability using compound loaded PLGA microcapsule after 72 hrs by MTT assay	[PMID: 30108718]

分子量

228.24

Formula

C₁₄H₁₂O₃

CAS 号

52436-88-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料

产品使用指南 (1538 KB)

参考文献

[1]. Clemente de Moraes D, et al. Effects of β-lapachone and β-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata. Bioorg Med Chem. 2022;63:116749. [Content Brief]

β-Nor-lapachone 相关分类

Infection

摩尔计算器
稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量		浓度		体积		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

浓度 _(start)	×	体积 _(start)	=	浓度 _(final)	×	体积 _(final)
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

β-Nor-lapachone52436-88-1FungalReactive Oxygen SpeciesAntibiofilmAntifungalCandida glabrataInhibitorinhibitorinhibit

您最近查看的产品:

产品名称：

* 需求量：

* 客户姓名：

* Email：

* 电话：

* 公司或机构名称：

留言给我们：

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4

上海工商

沪公网安备31011502019417

沪(浦)应急管危经许[2021]201709(QFYS)

营业执照（三证合一）

β-Nor-lapachone

Customer Review

β-Nor-lapachone 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

纯度 & 产品资料

参考文献

β-Nor-lapachone 相关分类

摩尔计算器

稀释计算器

The molarity calculator equation

The dilution calculator equation

Keywords:

您最近查看的产品:

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

产品名称：			* Lot #：
* 客户姓名：			* Email：
电话：			* 部门：
* 公司或机构名称：
留言给我们：

姓名
邮箱 *

Sorry, but the email address you supplied was invalid.

β-Nor-lapachone

Customer Review

β-Nor-lapachone 相关抗体

β-Nor-lapachone 相关产品

•同靶点产品:

•同靶点蛋白产品:

生物活性

纯度 & 产品资料

参考文献

β-Nor-lapachone 相关分类

摩尔计算器

稀释计算器

The molarity calculator equation

The dilution calculator equation

Keywords:

您最近查看的产品:

Request for HNMR Report

Request for HNMR Report

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z